Researchers worldwide now have access to the largest pool of make-on-demand molecules.
KYIV, UKRAINE, February 25, 2026 /EINPresswire.com/ — Chemspace, a global provider of chemical compounds and drug discovery services, today announced the integration of the xREAL Space by Enamine, a contract research organization and the world’s largest supplier of screening compounds and building blocks, into the Chemspace platform, allowing researchers to search and purchase trillions of compounds through a single online source.
This effort aims to address a critical bottleneck in early drug discovery. As virtual screening increasingly operates on a trillion-compound scale, researchers face a growing disconnect between computational hit identification and practical compound sourcing. Integration of Enamine xREAL Space bridges that gap, delivering more than simple catalog aggregation. Search results are provided using retrosynthetic analysis, enabling identification of hits in trillions of synthetically feasible molecules, which can then be purchased directly through the platform.
“The integration of Enamine’s trillion-scale collection marks a significant step in how discovery teams access and act with such massive collections,” said Olga Tarkhanova, PhD, CEO of Chemspace. She added: “For the first time, researchers are able to explore the world’s largest chemically feasible spaces and move directly to procurement.”
Volodymyr Ivanov, PhD, Executive Vice President at Enamine, commented: “For 35 years of its existence, Enamine has been working on charting synthetically accessible chemical space. Enamine REAL is its representation. We are happy that exploration of such a massive chemical universe has become fast and easy now.”
𝐀𝐛𝐨𝐮𝐭 𝐄𝐧𝐚𝐦𝐢𝐧𝐞: Enamine is a scientifically driven, integrated discovery Contract Research Organization with unique partnering opportunities in exploring new chemical space. The company combines access to the in-house produced screening compounds (4.7 million in stock) and building blocks (350,000 in stock) with a comprehensive platform of integrated discovery services to advance and accelerate the efforts in Drug Discovery.
For more information, visit: https://enamine.net
𝐀𝐛𝐨𝐮𝐭 𝐂𝐡𝐞𝐦𝐬𝐩𝐚𝐜𝐞: Chemspace is a global platform for discovering, designing, and delivering small molecules, providing integrated solutions for early-stage drug discovery through both online and offline platforms.
The Chemspace online platform offers a comprehensive solution for molecule discovery, purchasing, and procurement, enabling exploration of trillions of small molecules. With customizable catalog access, flexible purchasing options, and advanced compound management tools, the platform delivers a streamlined experience from search to synthesis.
The Chemspace offline platform provides end-to-end discovery services, including AI/ML-driven design, virtual screening, cheminformatics, and chemistry and biology services delivered in partnership with Enamine. This integrated approach supports hit identification, optimization, and biological validation within a coordinated workflow.
For more information, visit https://chem-space.com/search
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧
𝐄𝐧𝐚𝐦𝐢𝐧𝐞
Oleksii Gavrylenko
Director of Marketing
Email: o.gavrylenko@enamine.net
𝐂𝐡𝐞𝐦𝐬𝐩𝐚𝐜𝐞
Olga Tarkhanova, PhD
CEO
Email: o.tarkhanova@chem-space.com
https://chem-space.com/
Oleksii Gavrylenko
Enamine Ltd
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
